Breaks Categories: News

TuesdayJan 22, 2019 11:44 am

CBDNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Increased Revenues for Second Quarter 2019

ChineseInvestors.com (OTCQB: CIIX), developer of a proprietary financial news media and content platform providing information to the global Chinese-speaking community, this morning announced its financial and operational summary for the second quarter of fiscal year 2019. According to the update, revenues of $648,265 for the period were driven by stronger subscription and hemp/CBD sales revenues. The hemp and CBD sales segment achieved an increase of eight times the amount of the previous year while subscription revenues saw a year-over-year increase of over 40 percent. “We are beginning to see the positive results of investments made into existing markets as well…

Continue Reading

TuesdayJan 22, 2019 10:06 am

CBDNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Completes Equity Investment in Adult-Use Cannabis Beverage and Edibles Brand

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced its completion of an equity investment in 10663522 Canada Inc. (“Herbert”), a unique brand platform focused on the adult-use cannabis beverage and edibles market. Canopy Rivers subscribed in Herbert for CAD $1,500,000 of preferred shares and received incremental warrants that entitle RIV to certain governance-related rights and the ability to increase its economic interest in Herbert under certain circumstances. “Herbert represents an opportunity for Canopy Rivers to be invested at a very early stage in a company focused on the adult-use cannabis beverage and edible product segment,” Canopy Rivers President Narbe…

Continue Reading

TuesdayJan 22, 2019 10:00 am

CBDNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) Approved for Trading on the Frankfurt Stock Exchange; Appoints New Director

TransCanna Holdings (CSE: TCAN) announced on Monday that the company has been approved for trading on the Frankfurt Stock Exchange (XETR) under the listing TH8. In addition, TransCanna announced that Arni Johannson has accepted a seat on its board of directors. Johannson’s background includes extensive experience with operating and investing in emerging publicly traded companies. “We're excited with the ability to increase our shareholder base by being able to trade TransCanna on the Frankfurt Exchange,” TransCanna CEO Jim Pakulis stated in the news release. “We're also very pleased that Arni has agreed to join the board and assist in TransCanna's…

Continue Reading

FridayJan 18, 2019 9:29 am

CBDNewsBreaks – SinglePoint Inc. (SING) CEO Discusses Plans to Invest in CBD Commerce on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint Inc. (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is internationally-syndicated and reviews money-focused topics, featuring in-depth CEO and executive interviews from various companies offering insights into their operations and future outlooks. SinglePoint CEO Greg Lambrecht appeared on this week’s program and discussed the company’s investment plans, indicating that SING is looking to invest heavily into CBD commerce. To view the full press release, visit http://cnw.fm/EVXj3 About SinglePoint, Inc. SinglePoint, Inc. is a technology and investment company with a focus on acquiring companies that will benefit from the…

Continue Reading

ThursdayJan 17, 2019 11:45 am

CBDNewsBreaks – Golden Developing Solutions, Inc. (DVLP) Expanding “Where’s Weed” Segment and Primary Assets Following Blockbuster $18M in Transactions

Emerging leader in the cannabis, hemp, and cannabidiol (“CBD”) marketplace Golden Developing Solutions (OTC: DVLP) this morning announced the broad nationwide expansion of its Where’s Weed segment including its primary assets, the Where’s Weed Mobile App and WheresWeed.com. Where’s Weed provides an online and mobile cannabis services hub that focuses on providing fast, efficient and secure discovery, purchase and delivery scheduling of cannabis in U.S. and Canada across both recreational and medical markets. According to the update, DVLP’s Where’s Weed segment finished 2018 with blockbuster overall growth in annual hosting platform pre-purchase transactions of $18 million. Management believes this powerful…

Continue Reading

ThursdayJan 17, 2019 11:02 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Secures Up to $12M Altria Group Investment in DehydraTECH Technology

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has entered into a definitive agreement with Altria Group Inc. (NYSE: MO) to fund the research and development of Lexaria’s patented DehydraTECH technology. The company’s DehydraTECH enhances the performance of ingestible products’ beneficial compounds across four categories that include taste and smell, speed of action, bio-absorption and bioavailability. According to the update, the partnership will explore innovation in oral, reduced-risk nicotine products for consumers, as well as potentially commercialize DehydraTECH for oral nicotine delivery. “This is an…

Continue Reading

ThursdayJan 17, 2019 10:26 am

CBDNewsBreaks – Earth Science Tech, Inc. (ETST) Partners with Forzagen to Distribute CBD Products and Tap Into Fresh Territories throughout Mexico and South America

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) today announced its partnership with Forzagen to distribute ETST’s High Grade Full Spectrum Cannabinoids throughout Mexico and South America. Forzagen is a premium dietary supplements provider with a distribution network in Mexico and South America that enables product placement in retailers such as Sam’s Club and Pet Co. The partnership is timely, given Mexico’s permission of the import of CBD products and South America’s continued advancement in that direction. Under the partnership, ETST will also provide Forzagen exclusivity to distribute to all Latin American countries. “This partnership is an amazing opportunity for…

Continue Reading

ThursdayJan 17, 2019 10:17 am

CBDNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Appoints President with Strategic Career Pedigree

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced that it has appointed Narbe Alexandrian as president of the company, effective immediately. In this role, Alexandrian will report directly to CEO Bruce Linton with responsibilities that include leading corporate development initiatives and managing day-to-day corporate operations. Alexandrian’s experience prior to joining Canopy Rivers includes serving as a venture capitalist at OMERS Ventures, where he sourced and lead private debt and equity investments, assisted in raising over half a billion in capital for deployment in several of the firm’s investment funds, and acted as a board observer for several of the…

Continue Reading

ThursdayJan 17, 2019 9:52 am

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Launches Fourth Edition of Consumer Favorite Pink Lemonade Cannabis-Infused Gummies, National Parks Foundation to Receive Portion of Proceeds

Leading California edibles manufacturer Plus Products (CSE: PLUS) (OTCQB: PLPRF) this morning announced that it will create the fourth limited edition of its infused gummies - Pink Lemonade. Available for a limited time at select California dispensaries, a portion of this year’s launch proceeds will be donated to the National Parks Foundation. The Pink Lemonade product strikes a balance between sweet and tangy, providing a twist on a classic flavor and precise dosing of 3.5mg of THC and 1.5mg CBD. “Many people ask us how we come up with our new limited-edition flavors and the answer is, our customers. Pink…

Continue Reading

ThursdayJan 17, 2019 9:22 am

CBDNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Names Chief Science Officer

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, today announced the appointment of Dr. Rav Kumar, PhD as Chief Science Officer. Dr. Kumar will utilize his more than 25 years of experience in the pharmaceutical industry to lead TGOD’s Science & Innovation Division. He will also oversee all science-related initiatives, including its science portfolio of global product lines for patients and consumers, driving innovation from concept to commercialization. “We are incredibly excited to welcome Dr. Kumar to TGOD. He is a proven and seasoned senior executive with extensive international pharmaceutical experience in developing…

Continue Reading